190 related articles for article (PubMed ID: 32413024)
21. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
22. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus.
Weihua Z; Ekman J; Almkvist A; Saji S; Wang L; Warner M; Gustafsson JA
Biol Reprod; 2002 Aug; 67(2):616-23. PubMed ID: 12135905
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate.
Wu WF; Wang L; Spetsieris N; Boukovala M; Efstathiou E; Brössner C; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33771918
[TBL] [Abstract][Full Text] [Related]
24. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
Benbrahim-Tallaa L; Webber MM; Waalkes MP
Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
[TBL] [Abstract][Full Text] [Related]
26. Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.
Yun H; Xie J; Olumi AF; Ghosh R; Kumar AP
Oncotarget; 2015 May; 6(13):11600-13. PubMed ID: 25816367
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao F; Jin TY; Zhou YF
Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
[TBL] [Abstract][Full Text] [Related]
28. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
[TBL] [Abstract][Full Text] [Related]
31. Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats.
Morais-Santos M; Nunes AE; Oliveira AG; Moura-Cordeiro JD; Mahecha GA; Avellar MC; Oliveira CA
PLoS One; 2015; 10(7):e0131901. PubMed ID: 26147849
[TBL] [Abstract][Full Text] [Related]
32. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
[TBL] [Abstract][Full Text] [Related]
33. Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line.
Bimonte VM; Marampon F; Antonioni A; Fittipaldi S; Ferretti E; Pestell RG; Curreli M; Lenzi A; Vitale G; Brunetti A; Migliaccio S; Aversa A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451122
[TBL] [Abstract][Full Text] [Related]
34. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
[TBL] [Abstract][Full Text] [Related]
35. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.
Re A; Aiello A; Nanni S; Grasselli A; Benvenuti V; Pantisano V; Strigari L; Colussi C; Ciccone S; Mazzetti AP; Pierconti F; Pinto F; Bassi P; Gallucci M; Sentinelli S; Trimarchi F; Bacchetti S; Pontecorvi A; Lo Bello M; Farsetti A
Mol Endocrinol; 2011 Dec; 25(12):2003-16. PubMed ID: 22052999
[TBL] [Abstract][Full Text] [Related]
36. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
[TBL] [Abstract][Full Text] [Related]
37. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
[TBL] [Abstract][Full Text] [Related]
38. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
[TBL] [Abstract][Full Text] [Related]
39. High-fat diet obesity associated with insulin resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate.
Ribeiro DL; Pinto ME; Rafacho A; Bosqueiro JR; Maeda SY; Anselmo-Franci JA; Taboga SR; Góes RM
J Androl; 2012; 33(5):854-65. PubMed ID: 22441765
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
